Sajkowski Daniel J 4

4 · Calumet, Inc. /DE · Filed Jul 2, 2026

AI-generated summary of this filing

Updated Jul 2, 2026

Calumet (CLMT) Director Daniel Sajkowski Sells 4,240 Shares

What Happened

Daniel J. Sajkowski, a director of Calumet, Inc. (CLMT), sold 4,240 shares of company common stock on July 1, 2026.
The reported weighted-average sale price was $36.16 per share, for total proceeds of approximately $153,318. The shares were sold in multiple trades at prices ranging from $35.72 to $36.33.
This was a sale (routine disposition) rather than a purchase or award.

Key Details

Transaction date: 2026-07-01; Form 4 filed: 2026-07-02 (filed within the normal reporting window).
Shares sold: 4,240; weighted-average price: $36.16; total proceeds: ~$153,318.
Price range across trades: $35.72 to $36.33; reporting person can provide a breakdown of number of shares sold at each price on request (per footnote).
Footnote: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price on the plan adoption date was $19.08 per share.
Shares owned after the transaction: not specified in the provided filing.

Context

The sale was executed under a pre-established Rule 10b5-1 plan, which typically schedules trades in advance and helps insulate transactions from being viewed as opportunistic based on inside information. This is a routine insider sale and not direct evidence of company valuation changes.
For retail investors, purchases from insiders tend to carry more interpretive weight than routine sales; here, the filing documents a planned sale rather than a discretionary trade.

Form 4

Period: 2026-07-01

Director

Transactions

Sale
Common Stock, par value $0.01 per share
[F1][F2]
2026-07-01$36.16/sh−4,240$153,318→ 77,718 total

Footnotes (2)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.72 per share to $36.33 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Signature

/s/ Connor J. Egan, as attorney-in-fact|2026-07-02

1 file